Pre-transplant MRD negativity predicts favorable outcomes of CAR-T therapy followed by haploidentical HSCT for relapsed/refractory acute lymphoblastic leukemia: a multi-center retrospective study

Houli Zhao, Yongxian Hu, Jimin Shi et al.|Journal of Hematology & Oncology|2020

Cited by 82